We came across a bullish thesis on Penumbra, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on PENz. Penumbra, Inc.'s share was trading at $253.02 as of August 15th. PENz’s trailing and forward P/E were 66.94 and 71.43, respectively according to Yahoo Finance.
[caption id="attachment_519339" align="aligncenter" width="750"]Penumbra, Inc. is emerging as a key growth story in the medical device space, driven by its differentiated computer-assisted vacuum thrombectomy (CAVT)...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.